WuXi Biologics (Cayman) (FRA:1FW2) Long-Term Capital Lease Obligation : €290 Mil (As of Dec. 2023)

View and export this data going back to 2017. Start your Free Trial

What is WuXi Biologics (Cayman) Long-Term Capital Lease Obligation?

WuXi Biologics (Cayman)'s Long-Term Capital Lease Obligation for the quarter that ended in Dec. 2023 was €290 Mil.

WuXi Biologics (Cayman)'s quarterly Long-Term Capital Lease Obligation increased from Dec. 2022 (€202 Mil) to Jun. 2023 (€284 Mil) and increased from Jun. 2023 (€284 Mil) to Dec. 2023 (€290 Mil).

WuXi Biologics (Cayman)'s annual Long-Term Capital Lease Obligation increased from Dec. 2021 (€199 Mil) to Dec. 2022 (€202 Mil) and increased from Dec. 2022 (€202 Mil) to Dec. 2023 (€290 Mil).

WuXi Biologics (Cayman) Long-Term Capital Lease Obligation Historical Data

The historical data trend for WuXi Biologics (Cayman)'s Long-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

WuXi Biologics (Cayman) Long-Term Capital Lease Obligation Chart

WuXi Biologics (Cayman) Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Long-Term Capital Lease Obligation

Get a 7-Day Free Trial

34.15

83.78

198.60

201.70

290.12

WuXi Biologics (Cayman) Semi-Annual Data
	Dec14	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Long-Term Capital Lease Obligation	Get a 7-Day Free Trial													198.60	196.86	201.70	283.69	290.12

WuXi Biologics (Cayman) (FRA:1FW2) Long-Term Capital Lease Obligation Explanation

Long-Term Capital Lease Obligation are the amount due for long-term asset lease agreements that are nearly equivalent to asset purchases. Capital lease obligations are installment payments that constitute a payment of principal plus interest for the capital lease. The Short-Term Capital Lease Obligation is the portion of a Long-Term Capital Lease Obligation that is due over the next year.

Under US Generally Accepted Accounting Principles (GAAP), a capital lease is essentially equivalent to a purchase by the lessee if it meets the following criteria:

1. Ownership of the asset is transferred to the lessee at the end of the lease term;
2. The lease contains a bargain purchase option to buy the equipment at less than fair market value;
3. The lease term equals or exceeds 75% of the asset's estimated useful life;
4. The present value of the lease payments equals or exceeds 90% of the total original cost of the equipment.

WuXi Biologics (Cayman) Long-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of WuXi Biologics (Cayman)'s Long-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

WuXi Biologics (Cayman) (FRA:1FW2) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » WuXi Biologics (Cayman) Inc (FRA:1FW2) » Definitions » Long-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

WXIBF:USA WXXWY:USA 2269:Mexico 02269:Hong Kong 1FW1:Germany

Address

No. 108, Meiliang Road, Mashan Binhu District, Wuxi, CHN, 214092

Website

https://www.wuxibiologics.com

WuXi Biologics is one of the largest global biologics CRDMOs. WuXi Biologics, incorporated in 2014 following the reorganization of WuXi PharmaTech, later known as WuXi AppTec, now has global revenue of CNY 15 billion. North American represented 55.6% of total revenue in 2022. It adopts the follow and win the molecule strategy by providing end-to-end services, from drug discovery to commercial manufacturing. It also adopts a global dual-sourcing strategy by providing drug products and large-scale drug substance manufacturing.

WuXi Biologics (Cayman) (FRA:1FW2) Headlines

No Headlines